Search Press releases Keywords From To 25 May 2011 UCB to conduct first anti-TNF head-to-head study between Cimzia® (certolizumab pegol) and Humira®* (adalimumab) Read More 19 May 2011 Acquisition of own shares by UCB SA/NV Read More 17 May 2011 Call for Entries: International Bureau for Epilepsy and UCB launch the 2011 Excellence in Epilepsy Journalism Award to recognise outstanding reporting on epilepsy Read More 16 May 2011 Baxter, UCB, TRI-VIZOR and H.Essers announce world’s first example of “orchestrated carpooling for cargo” Read More 16 May 2011 Novel ACR hybrid score in rheumatoid arthritis applied for the first time to data from the RAPID 1 study with Cimzia® (certolizumab pegol) Read More 12 May 2011 Acquisition of own shares in the framework of employees’ long-term incentive plans Read More Pagination First page Previous page Previous … Page 146 Page 147 Page 148 Page 149 Current page 150 Page 151 Page 152 Page 153 Page 154 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
